JOHN P. LONGENECKER PHD - 03 Mar 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
03 Mar 2022
Net transactions value
-$426,475
Form type
4
Filing time
07 Mar 2022, 19:03:47 UTC
Previous filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $75,670 +7,000 +37% $10.81 25,823 03 Mar 2022 Direct
transaction PCRX Common Stock Sale $502,145 -7,000 -27% $71.74 18,823 03 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -7,000 -100% $0.000000* 0 03 Mar 2022 Common Stock 7,000 $10.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 5, 2012.